MAPK3 and breast cancer: Thus, our data indicate that the direct route might be the main determinant of ERα S118 phosphorylation in obese patients, supported by a study from breast cancer indicating that estrogen-induced ERα S118 phosphorylation occurs independently of Erk1 and Erk2 (MAPK) [26].